Changeflow GovPing Healthcare & Life Sciences Metagenomics Study Examines Lung Infections in ...
Routine Notice Added Final

Metagenomics Study Examines Lung Infections in Critically Ill Children

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH registered ClinicalTrials.gov study NCT07545096 on April 22, 2026, an observational investigation of metagenomics for detecting pathogens in critically ill children with suspected chest infections. The study will collect lung fluid and blood samples from intubated pediatric ICU patients to determine whether immune responses indicate bacterial or viral infection, potentially enabling targeted antibiotic therapy. This is an informational research registration with no compliance obligations for external parties.

“This project explores whether measuring how the body is reacting to the bugs gives precise information about which bug is actually making them sick.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 686 changes logged to date.

What changed

A new clinical research study was registered on ClinicalTrials.gov describing an observational investigation into metagenomic sequencing for diagnosing respiratory infections in critically ill children. The study will enroll intubated pediatric ICU patients and analyze lung fluid samples alongside blood samples to determine whether immune responses indicate bacterial or viral infection. If successful, the findings could inform more targeted antibiotic prescribing in pediatric critical care settings.

Institutions conducting pediatric critical care research and companies developing metagenomic diagnostic platforms may find this study relevant to their programs. The study carries no compliance obligations for external parties and represents an informational research registration.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Host Response and Pathogen Genomics in Childhood Respiratory Infection

Observational NCT07545096 Kind: OBSERVATIONAL Apr 22, 2026

Abstract

A major challenge in children's infections is that it is difficult to work out which bug is making them unwell. Tests can find the bugs that are present though there can be more than one. Some bugs may just be bystanders and not actually making the child sick. Children still receive antibiotics because it is not always clear that they don't need them.

This project explores whether measuring how the body is reacting to the bugs gives precise information about which bug is actually making them sick. It will investigate children in intensive care who are suspected of having a chest infection.

This study uses a novel technology called "metagenomics" to detect any bacteria or viruses in the lung. Alongside this, investigators will measure how the lungs respond to the bugs through further tests of cells and proteins collected from the lung fluid. This fluid will be tested to see if the response is due to bacteria or viruses.

Collecting lung fluid samples requires that children are sedated and intubated, having a breathing tube in place. This means that only children intubated in intensive care are eligible. Extra samples of lung fluid and blood will be collected when being taken for routine clinical care.

If these tests work, they have the potential to give rapid and accurate information about what type of infection is taking place in the lung. This means the correct antibiotics can be given to children who need them and avoid the harms of giving them to children who do not....

Conditions: Pneumonia

Interventions: Non-Interventional Study

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
NCT07545096

Who this affects

Applies to
Healthcare providers Nonprofits
Industry sector
6211 Healthcare Providers 5417 Scientific Research
Activity scope
Clinical research Pediatric critical care Metagenomic diagnostics
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Public Health Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!